A rational approach to genetic testing for sarcoma

Diagnostic Molecular Pathology

Volumn 18, Issue 1, 2009, Pages 1-10

  Gulley, Margaret L ^a   Kaiser Rogers, Kathleen A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar rhabdomyosarcoma; Ewing sarcoma; Gene test; Neuroblastoma; Sarcoma; Synovial sarcoma

Indexed keywords

DESMOPLASTIC ROUND CELL TUMOR; IMATINIB; RAPAMYCIN; TRASTUZUMAB; UNCLASSIFIED DRUG; TUMOR MARKER;

ALVEOLAR SOFT PART SARCOMA; ANEURYSMAL BONE CYST; ANGIOMATOID FIBROUS HISTIOCYTOMA; CANCER DIAGNOSIS; CHROMOSOME REARRANGEMENT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLEAR CELL SARCOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; CYTOPATHOLOGY; DERMATOFIBROSARCOMA PROTUBERANS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIAGNOSTIC PROCEDURE; EMBRYONAL RHABDOMYOSARCOMA; ENDOMETRIUM SARCOMA; EOSINOPHILIC LEUKEMIA; EWING SARCOMA; FIBROMYXOID SARCOMA; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR DENDRITIC CELL SARCOMA; GASTROINTESTINAL STROMAL TUMOR; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC DISORDER; HEMANGIOPERICYTOMA; HISTIOCYTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INFANTILE FIBROSARCOMA; KAPOSI SARCOMA; KARYOTYPING; LABORATORY TEST; LEIOMYOSARCOMA; LIPOBLASTOMA; LIPOMA; LIPOSARCOMA; MESOBLASTIC NEPHROMA; MORPHOLOGY; MUTATION; MYXOID CHONDROSARCOMA; MYXOSARCOMA; NEUROBLASTOMA; NEUROFIBROSARCOMA; PATHOGENESIS; PLASMA CELL GRANULOMA; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TENOSYNOVIAL GIANT CELL TUMOR; GENETICS; IN SITU HYBRIDIZATION; METHODOLOGY; MICROARRAY ANALYSIS; PATHOLOGY; POLYMERASE CHAIN REACTION;

HUMANS; IN SITU HYBRIDIZATION; KARYOTYPING; MICROARRAY ANALYSIS; PATHOLOGY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 62449219420     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318181fa05     Document Type: Review

References (60)

1. Chang CC, Shidham VB. Molecular genetics of pediatric soft tissue tumors: clinical application. J Mol Diagn. 2003;5:143-154.
2. Ladanyi M. Translocation-based molecular diagnosis of sarcomas. Am J Surg Pathol. 2003;27:414-415; author reply 415-416.
3. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002; 62:135-140.
4. Davicioni E, Finckenstein FG, Shahbazian V, et al. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res. 2006;66:6936-6946.
5. Schofield D, Triche TJ. cDNA microarray analysis of global gene expression in sarcomas. Curr Opin Oncol. 2002;14:406-411.
6. Hancock JD, Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle. 2008; 7:250-256.
7. Dumur CI, Lyons-Weiler M, Sciulli C, et al. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J Mol Diagn. 2008;10:67-77.
8. Singer S, Socci ND, Ambrosini G, et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res. 2007;67:6626-6636.
9. Tschoep K, Kohlmann A, Schlemmer M, et al. Gene expression profiling in sarcomas. Crit Rev Oncol Hematol. 2007;63:111-124.
10. Jin L, Majerus J, Oliveira A, et al. Detection of fusion gene transcripts in fresh-frozen and formalin-fixed paraffin-embedded tissue sections of soft-tissue sarcomas after laser capture micro-dissection and rt-PCR. Diagn Mol Pathol. 2003;12:224-230.
11. Lewis TB, Coffin CM, Bernard PS. Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod Pathol. 2007;20:397-404.
12. Athale UH, Shurtleff SA, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol. 2001;23:99-104.
13. Carpentieri DF, Qualman SJ, Bowen J, et al. Protocol for the examination of specimens from pediatric and adult patients with osseous and extraosseous Ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and Ewing sarcoma. Arch Pathol Lab Med. 2005;129:866-873.
14. Gulley ML, Braziel RM, Halling KC, et al. Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med. 2007;131: 852-863.
15. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol. 2006;19:659-668.
16. Xia SJ, Barr FG. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur J Cancer. 2005;41: 2513-2527.
17. Huang HY, Illei PB, Zhao Z, et al. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol. 2005;23: 548-558.
18. Kilpatrick SE, Bergman S, Pettenati MJ, et al. The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas. Mod Pathol. 2006;19:815-819.
19. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005;18:1585-1590.
20. Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn. 2007;9:498-509.
21. Bode-Lesniewska B, Frigerio S, Exner U, et al. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Genes Chromosomes Cancer. 2007; 46:961-971.
22. Barr FG, Womer RB. Molecular diagnosis of ewing family tumors: too many fusions? J Mol Diagn. 2007;9:437-440.
23. Qian X, Jin L, Shearer BM, et al. Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol. 2005;14:23-28.
24. Lin PP, Brody RI, Hamelin AC, et al. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res. 1999;59:1428-1432.
25. Schleiermacher G, Peter M, Oberlin O, et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol. 2003;21:85-91.
26. Vermeulen J, Ballet S, Oberlin O, et al. Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour. Br J Cancer. 2006;95:1326-1333.
27. Bridge RS, Rajaram V, Dehner LP, et al. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol. 2006;19:1-8.
28. Friedrichs N, Kriegl L, Poremba C, et al. Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study. Diagn Mol Pathol. 2006;15:83-89.
29. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med. 2008;132: 326-348.
30. Heim-Hall J, Yohe SL. Application of immunohistochemistry to soft tissue neoplasms. Arch Pathol Lab Med. 2008;132:476-489.
31. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008;32:8-13.
32. Hameed M. Small round cell tumors of bone. Arch Pathol Lab Med. 2007;131:192-204.
33. Wang LL, Perlman EJ, Vujanic GM, et al. Desmoplastic small round cell tumor of the kidney in childhood. Am J Surg Pathol. 2007;31:576-584.
34. Hill DA, Riedley SE, Patel AR, et al. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital. Pediatr Dev Pathol. 2003;6:24-34.
35. Mehra S, de la Roza G, Tull J, et al. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation. Diagn Mol Pathol. 2008;17:14-20.
36. Matsumura T, Yamaguchi T, Seki K, et al. Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas. Virchows Arch. 2008;452:251-258.
37. Yamamoto H, Kohashi K, Oda Y, et al. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. Pathol Int. 2006;56:584-590.
38. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn. 2001;3:1-10.
39. Shek TW, Ho FC, Ng IO, et al. Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol. 1996;20:313-324.
40. Jenson HB, Leach CT, McClain KL, et al. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma. 1997;27:303-314.
41. Ryan JL, Fan H, Glaser SL, et al. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004;6:378-385.
42. Mergan F, Jaubert F, Sauvat F, et al. Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis. J Pediatr Surg. 2005;40:1581-1586.
43. Cesarman E, Mesri EA. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Curr Top Microbiol Immunol. 2007;312:263-287.
44. Bonatti H, Hoefer D, Rogatsch H, et al. Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc. 2005;37: 1839-1844.
45. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005;352: 1317-1323.
46. Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene. 2003;22:5122-5130.
47. Pan L, Milligan L, Michaeli J, et al. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn. 2001; 3:32-38.
48. Fan H, Gulley ML. Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn. 2001;6:279-289.
49. Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 2005;65:8984-8992.
50. Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9: 1941-1956.
51. Uren A, Toretsky JA. Pediatric malignancies provide unique cancer therapy targets. Curr Opin Pediatr. 2005;17:14-19.
52. Patel KU, Szabo SS, Hernandez VS, et al. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol. 2008;39: 184-193.
53. Barr FG, Zhang PJ. The impact of genetics on sarcoma diagnosis: an evolving science. Clin Cancer Res. 2006;12:5256-5257.
54. Chen QR, Vansant G, Oades K, et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn. 2007;9:80-88.
55. Johnsen JI, Segerstrom L, Orrego A, et al. Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene. 2008; 27:2910-2922.
56. Montaner S. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle. 2007;6:438-443.
57. Dittmer DP, Krown SE. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus. Curr Opin Oncol. 2007; 19:452-457.
58. Bedell V, Forman SJ, Gaal K, et al. Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections. J Mol Diagn. 2007;9:589-597.
59. Bzorek M Sr, Petersen BL, Hansen L. Simultaneous phenotyping and genotyping (FICTION-methodology) on paraffin sections and cytologic specimens: a comparison of 2 different protocols. Appl Immunohistochem Mol Morphol. 2008;16:279-286.
60. Hill DA, O'Sullivan MJ, Zhu X, et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol. 2002; 26:965-977.